1. Home
  2. MDWD vs DSP Comparison

MDWD vs DSP Comparison

Compare MDWD & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$13.80

Market Cap

181.1M

Sector

Health Care

ML Signal

HOLD

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

HOLD

Current Price

$12.98

Market Cap

265.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDWD
DSP
Founded
2000
1999
Country
Israel
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
181.1M
265.1M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
MDWD
DSP
Price
$13.80
$12.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$36.00
$17.81
AVG Volume (30 Days)
57.3K
299.5K
Earning Date
05-20-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.14
EPS
N/A
N/A
Revenue
N/A
$344,201,000.00
Revenue This Year
$48.92
$20.27
Revenue Next Year
$35.04
$16.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.00
52 Week Low
$13.46
$8.11
52 Week High
$20.30
$14.80

Technical Indicators

Market Signals
Indicator
MDWD
DSP
Relative Strength Index (RSI) 36.09 55.24
Support Level N/A $10.65
Resistance Level $15.08 $13.76
Average True Range (ATR) 0.48 0.81
MACD -0.05 0.13
Stochastic Oscillator 4.81 53.44

Price Performance

Historical Comparison
MDWD
DSP

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.

Share on Social Networks: